(Q42814705)

7 November 2017

Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates (English)

1 reference

7 November 2017

0 references

Yi Luo

1

1 reference

7 November 2017

Nicole J Bernshaw

2

1 reference

7 November 2017

Zheng-Rong Lu

3

1 reference

7 November 2017

Jindrich Kopecek

4

1 reference

7 November 2017

Glenn D Prestwich

5

1 reference

7 November 2017

1 April 2002

1 reference

7 November 2017

Pharmaceutical Research

1 reference

7 November 2017

19

1 reference

7 November 2017

4

1 reference

7 November 2017

396-402

1 reference

CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration

7 November 2017

1 reference

12 December 2020

A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells

1 reference

12 December 2020

Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential

1 reference

12 December 2020

Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression

1 reference

12 December 2020

Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee

1 reference

12 December 2020

Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites

1 reference

12 December 2020

Cell-based screen for identification of inhibitors of tubulin polymerization.

1 reference

12 December 2020

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

1 reference

12 December 2020

Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody

1 reference

12 December 2020

Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis

1 reference

12 December 2020

Potential use of serum CD44 as an indicator of tumour progression in acute leukemia

1 reference

12 December 2020

Tumor-associated hyaluronan. Providing an extracellular matrix that facilitates invasion.

1 reference

12 December 2020

Anthracycline immunoconjugates prepared by a site-specific linkage via an amino-dextran intermediate carrier.

1 reference

12 December 2020

HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action

1 reference

12 December 2020

Polymerizable Fab' antibody fragments for targeting of anticancer drugs

1 reference

12 December 2020

Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade

1 reference

12 December 2020

Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo.

1 reference

12 December 2020

Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan

1 reference

12 December 2020

Polymer-bound camptothecin: initial biodistribution and antitumour activity studies

1 reference

12 December 2020

HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro

1 reference

12 December 2020

Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate

1 reference

12 December 2020

Inhibition of tumor growth in vivo by hyaluronan oligomers

1 reference

12 December 2020

Expression of CD44 variants in lung cancer and its relationship to hyaluronan binding

1 reference

12 December 2020

Receptor for hyaluronan-mediated motility and CD44 expressions in colon cancer assessed by quantitative analysis using real-time reverse transcriptase-polymerase chain reaction.

1 reference

12 December 2020

Evaluation of antitumor activities of hyaluronate binding antitumor drugs: synthesis, characterization and antitumor activity

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1015170907274

1 reference

7 November 2017

1 reference